Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Skrit37on Nov 30, 2020 3:28pm
96 Views
Post# 32002492

RE:RE:ACTUAL STOCK / SZLS COMMENTS

RE:RE:ACTUAL STOCK / SZLS COMMENTS
2020oilgamble wrote: It is not that Q3 needs to be restated (again.)   It is more accurate to say that some of the 'activity' which the company completed, while even potentially invoiced, is not recorded as revenue until the money/cash is received.

It is different than most people are used to, but it is a real way of doing things.

So it will be correctly recorded as Q4 revenue, although some of the testing my have been performed in Q3.


Newfinvest wrote: Does anyone know if the remaining revenue from COVID testing completed in Q3 will only be reported and restated in Q4 release or if they will restate/update before then? As outlined previously, these tests fall into CASH SALES category and lagging info is associated with it... meaning actual Q3 revenue is likely higher than currently reported. Also... have an opinion (positive or negative) and keep it from being so childish and personal. Its unreal how immature this message board has become... and it is not one sided. People... surely you can just move on and take the high road.




Exactly oilgamble..you say it much better then me haha....I think if Mr. Tripp gives us a 4-6 week collected revenue statement again...these revenues will obviously be included ...I believe this will be a significant # which will be added too cash received q4 revenue Thus far....I think jaws will drop!
<< Previous
Bullboard Posts
Next >>